title: A spread containing bioactive milk peptides Ile-Pro-Pro and Val-Pro-Pro, and plant sterols has antihypertensive and cholesterol-lowering effects.
abstract: Lifestyle intervention is recommended as the primary treatment for mild hypertension and hypercholesterolemia. We studied the effects of a spread containing bioactive milk peptides IPP and VPP, as well as plant sterols, on cardiovascular risk factors in 104 hypertensive, hypercholesterolemic subjects in a randomised, placebo-controlled double-blind intervention. Middle-aged subjects consumed 20 g day⁻¹ of a spread containing 4.2 mg of IPP and VPP as well as 2 g of plant sterols for 10 weeks after a 2 week run-in period. Blood pressure was measured at home 3 times a week. Office blood pressure and 24 h ambulatory blood pressure measurements were performed at the end of the run-in and intervention periods. Blood samples were analysed for serum lipids, plasma glucose and inflammation markers. A significant decrease (-4.1 mmHg vs. -0.5 mmHg, p = 0.007) in systolic blood pressure was seen in the active group, compared to placebo at home measurements. Office blood pressure and 24 h nighttime or daytime ambulatory systolic or diastolic pressure did not differ between the groups. Total (-0.16 vs. 0.25 mmol l⁻¹, p = 0.005) and LDL cholesterol (-0.16 vs. 0.18 mmol l⁻¹, p = 0.006) decreased significantly in the active group compared to the placebo. No significant differences between groups were seen for plasma glucose or inflammation markers. The results thus suggest that milk peptides IPP and VPP and plant sterols, in a low-fat spread matrix, produce a clinically significant reduction in systolic blood pressure as well as serum total and LDL cholesterol without adverse effects. Functional foods that affect 2 major risk factors offer a safe and convenient way to reduce the risk of cardiovascular disease by supporting lifestyle intervention.
authors.affiliation: Valio Ltd, R&D, P.O. Box 30, 00039 Valio, Finland. anu.turpeinen@valio.fi
authors.forename: Anu M
authors.initials: AM
authors.lastname: Turpeinen
authors.forename: Mikko
authors.initials: M
authors.lastname: Ikonen
authors.forename: Anne S
authors.initials: AS
authors.lastname: Kivimäki
authors.forename: Hannu
authors.initials: H
authors.lastname: Kautiainen
authors.forename: Heikki
authors.initials: H
authors.lastname: Vapaatalo
authors.forename: Riitta
authors.initials: R
authors.lastname: Korpela
mesh_terms: D000328:Adult; D000368:Aged; D000818:Animals; D000924:Anticholesteremic Agents / Q000008:administration & dosage* / Q000378:metabolism; D000959:Antihypertensive Agents / Q000008:administration & dosage* / Q000378:metabolism; D001786:Blood Glucose / Q000378:metabolism; D001794:Blood Pressure / Q000187:drug effects; D002417:Cattle; D008078:Cholesterol, LDL / Q000378:metabolism; D004311:Double-Blind Method; D005260:Female; D005285:Fermentation; D006801:Humans; D006937:Hypercholesterolemia / Q000178:diet therapy* / Q000378:metabolism; D006973:Hypertension / Q000178:diet therapy* / Q000378:metabolism / Q000503:physiopathology; D052198:Lactobacillus helveticus / Q000378:metabolism; D008297:Male; D008383:Margarine / Q000032:analysis* / Q000382:microbiology; D008875:Middle Aged; D008892:Milk / Q000737:chemistry* / Q000378:metabolism / Q000382:microbiology; D010455:Peptides / Q000008:administration & dosage* / Q000378:metabolism; D010840:Phytosterols / Q000008:administration & dosage* / Q000378:metabolism
chemical_list: D000924:Anticholesteremic Agents; D000959:Antihypertensive Agents; D001786:Blood Glucose; D008078:Cholesterol, LDL; D010455:Peptides; D010840:Phytosterols; D008383:Margarine